| Literature DB >> 28930173 |
Diego Dos Santos Baião1, Cyntia Silva de Freitas2, Laidson Paes Gomes3, Davi da Silva4, Anna Carolina N T F Correa5, Patricia Ribeiro Pereira6, Eduardo Mere Del Aguila7, Vania Margaret Flosi Paschoalin8.
Abstract
Throughout evolution, plants have developed the ability to produce secondary phenolic metabolites, which are important for their interactions with the environment, reproductive strategies and defense mechanisms. These (poly)phenolic compounds are a heterogeneous group of natural antioxidants found in vegetables, cereals and leguminous that exert beneficial and protective actions on human health, playing roles such as enzymatic reaction inhibitors and cofactors, toxic chemicals scavengers and biochemical reaction substrates, increasing the absorption of essential nutrients and selectively inhibiting deleterious intestinal bacteria. Polyphenols present in some commodity grains, such as soy and cocoa beans, as well as in other vegetables considered security foods for developing countries, including cassava, taro and beetroot, all of them cropped in Brazil, have been identified and quantified in order to point out their bioavailability and the adequate dietary intake to promote health. The effects of the flavonoid and non-flavonoid compounds present in these vegetables, their metabolism and their effects on preventing chronic and degenerative disorders like cancers, diabetes, osteoporosis, cardiovascular and neurological diseases are herein discussed based on recent epidemiological studies.Entities:
Keywords: beetroot; cassava; cocoa nibs; soybeans andantioxidant activity; taro
Mesh:
Substances:
Year: 2017 PMID: 28930173 PMCID: PMC5622804 DOI: 10.3390/nu9091044
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Figure 1Schematic representation of the main classes and subclasses of phenolic compounds and their respective chemical structure backbone, where C6 corresponds to the aromatic ring and C1, C2 or C3 refers to side chains or intermediate chains.
Figure 2Chemical structures of phenolic acids, adapted from the database “Polyphenol content in foods” (http://phenol-explorer.eu). Gallic acid and vanillin acid belongs to benzoic acids subclass, characterized by a backbone composed of 7 carbons (C6-C1). Caffeic acid, ferric acid and p-coumaric acid represent the cinnamic acids subclass and exhibit a backbone composed of 9 carbons (C6-C3) [1].
Figure 3Representative chemical structures of the main subclasses and basic structure of the majority of flavonoids, adapted from the database “Polyphenol content in foods” (http://phenol-explorer.eu) [1].
Figure 4Chemical structures of the stilbene and lignan classes, adapted from the database “Polyphenol content in foods” (http://phenol-explorer.eu) [1].
Flavonoid and non-flavonoid compounds plant sources.
| Plant Source | Polyphenols | Class | Compound | Ref. |
|---|---|---|---|---|
| Beetroot | flavonoids | flavanone | betagarin | [ |
| flavone | cochliophilin a | [ | ||
| flavonol | dihydroisorhamnetin | [ | ||
| isoflavone | betavulgarin | [ | ||
| non-flavonoids | hydrobenzoic acids | [ | ||
| hydroxycinnamic acids | caffeic acid, ferulic acid, gallic acid, | [ | ||
| Cassava | flavonoids | anthocyanidins | cyanidin, delphinidin | [ |
| flavan-3-ols | catechin, gallocatechin | [ | ||
| flavonols | kaempferol, quercetin, rutin | [ | ||
| non-flavonoids | coumarins | scopoletin | [ | |
| hydrobenzoic acids | coniferaldehyde, gallic acid, isovanillin, syringsledehyde, resveratrol | [ | ||
| hydroxycinnamic acids | chlorogenic acid, | [ | ||
| lignans | balanophonin, pinoresinol | [ | ||
| stilbene | [ | |||
| Cocoa nibs | flavonoids | anthocyanidins | arabinosidil, cyaniding, galactosidyl | [ |
| flavan-3-ols | cathechin, epicatechin, hyperoside, isovitexin, procyanidin b1, procyanidin b2, vitexin | [ | ||
| flavonols | quercetin, quercetin 3- | [ | ||
| flavonones | apigenin, luteolin, luteolin-7- | [ | ||
| tannins | procyanidins | [ | ||
| Soybean | flavonoids | anthocyanidins | cyanidin, delphinidin, pelargonidin, petunidin | [ |
| hydrobenzoic acids | gallic acid, gentistic, protocatechuic acid | [ | ||
| non-flavonoids | hydroxycinnamic acids | caffeic acid, chlorogenic acid, ferulic acid, sinapic acid, | [ | |
| isoflavonoids | β-glucosides: daidzin, genistin, glycitin | [ | ||
| Taro | flavonoids | anthocyanidins | cyanidin, delphinidin | [ |
| flavonols | isorhamnetin, kaempferol, myricetin, quercetin | [ | ||
| non-flavonoids | hydroxycinnamic acids | chlorogenic acid, | [ |
Figure 5Polyphenolsfrom vegetables popularly consumed in Brazil—taro, beetroot, cassava, soybean and cocoa—and their effects on human health promotion and diseases.
Human intervention studies evaluating the effects of polyphenols or polyphenol-enriched foods on health and diseases.
| Polyphenols Source | Polyphenol Content(s) | Experimental Population | Number of Volunteers | Duration (Days) | Effect(s) |
|---|---|---|---|---|---|
| Isolated soy protein containing moderate and high isoflavones concentration | Two dietary groups: | Hypercholesterolemic postmenopausal women | 66 | 168 | Increases HDL cholesterol, mononuclear cell LDL receptor mRNA, both bone mineral content and density in the lumbar spine after ingestion of two dietary groups decreases in non-HDL cholesterol after ingestion of the two dietary groups (56 and 90 mg of isoflavones) [ |
| Genistein (soy phytoestrogen) | 54 mg | Healthy and postmenopausal women (range 47–57 years) | 90 | 364 | Decreased excretion of pyridinium and deoxypyridinoline (PYR: −54 ± 10%; DPYR: −55 ± 13%) after 6 and 12 (PYR: −42 ± 12%; DPYR: −44 ± 16%) months of genistein administration. Increases in serum bone-specific ALP (B-ALP) and osteocalcin (bone Gla protein [BGP]) after 6 (B-ALP: 23 ± 4%; BGP: 29 ± 11%) and 12 (B-ALP: 25 ± 7%; BGP: 37 ± 16%) months of genistein administration. Furthermore, significantly increases in femur (femoral neck: 3.6 ± 3% and lumbar spine (3 ± 2%) bone mineral density (BMD) were observed [ |
| Textured soy protein high in isoflavones (HI); | HI | Healthy men and women (range 19–40 years) | 24 | 14 | Decreased plasma 8-epi-PGF2α after high-isoflavone dietary treatment (326 ± 32 ng L−1) when compared to the low-isoflavone dietary treatment (405 ± 50 ng L−1). The lag time for copper-ion-induced LDL oxidation was longer after high-isoflavone dietary treatment (48 ± 2.4 min) than low-isoflavone dietary treatment (44 ± 1.9 min). No changes in plasma malondialdehyde, LDL α-tocopherol, polyunsaturated fatty acids, and isoflavonoids after dietary treatments [ |
| Cocoa supplementation (dark chocolate bar and cocoa powder drink) | 651 mg of procyanidins | Healthy men and women (range 20 to 60 years) | 25 | 42 | Decreased LDL oxidizability (evidenced by a longer lag time, 101.0 ± 20.7 min) after cocoa supplementation compared with baseline (91.3 ± 18.0 min) and washout (96.4 ± 7.5 min). No changes in urinary F(2) isoprostane concentration and markers of inflammation including the whole-blood cytokines, interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha, high sensitivity C-reactive protein and P-selectin [ |
| Cocoa drink | 821 mg of total flavonoids | Healthy men and women (range 18–72 years) | 27 | 35 | Increased peripheral vasodilation after four days of cocoa drink ingestion. After five days of cocoa drink consumption, pulse wave amplitude exhibited a large additional acute response [ |
| Cocoa drink | 176 mg of flavan-3-ols (70 mg of epicatechin plus catechin and 106 mg of procyanidins) | Outpatients with at least 1 cardiovascular risk factor (means, 41 years) | 26 | 2 | Increased flow-mediated dilatation maximally at 2 h from 3.4% to 6.3% after cocoa drink ingestion. Increases nitrosylated and nitrosated species from 22 to 36 nmol L−1 after ingestion of cocoa rich in flavan-3-ols [ |
| Dark chocolate | 15.6 mg of epicatechin equivalents per gram | Heart transplant recipients volunteers (range 35–70 years) | 22 | Acute | Increased coronary artery diameter from 2.36 ± 0.51 to 2.51 ± 0.59 mm after ingestion of flavonoid-rich dark chocolate. Decreased platelet adhesion from 4.9 ± 1.1% to 3.8 ± 0.8% after ingestion of flavonoid-rich dark chocolate [ |
| Powder cocoa drink | 963 mg of flavonoids | Diabetes mellitus II men and women (for at least 5 years, range 50 to 80 years) | 41 | 28 | Increased flow-mediated dilatation (FMD) by 30% after ingestion of flavanol-containing cocoa. Treatment was well tolerated, without evidence of tachyphylaxia. No changes in endothelium-independent responses, blood pressure, heart rate, and glycemic control after ingestion of the cocoa drink [ |